PROVIDER PROFILE · NPI 1164659348

Cristina Cabret AymatM.D.

NeurologyGuaynabo, PRI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,442

Beneficiaries

—

Total drug cost

$762K

Distinct drugs

Brand share

63.2%

Top prescribed drugs

Ubrogepant232 claims

Galcanezumab-Gnlm222 claims

Rimegepant Sulfate189 claims

Gabapentin87 claims

Memantine Hcl84 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$17K

Payment records

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$9K

Consulting Fee$7K

Travel and Lodging$1K

Food and Beverage$548

REFERRAL NETWORK

Where Cristina Cabret Aymat's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 1 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
SCOTT & WHITE MEMORIAL HOSPITAL	99	899

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
SCOTT & WHITE MEMORIAL HOSPITAL	114	1,330

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history